Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of ZhongFengHuiYu Granule for ischemic stroke with non-fluent aphasia
CTR20210496Phase 2Active
- Sponsor
- Changchun University of Chinese Medicine
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zhongfeng huiyu in ischemic stroke, sponsored by Changchun University of Chinese Medicine. Started Jun 2021; status: active.
02
Drugs
zhongfeng huiyu
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20210496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210496.